topicBerberine Glycemic Control Meta-Analysis
claimThese conditions frequently co-occur, with obesity-related complications often clustering together rather than presenting independently [,] and individuals with obesity-associated diabetes commonly show a higher burden of dyslipidemia as well, as evidenced by the fact that combined control of glycemic, blood pressure, and lipid targets is achieved in only a minority of these patients [].
evidence level1
citationKang Chae-Yeon (2026)
sourceCoptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study
topicBerberine Glycemic Control Meta-Analysis
claimThe resulting insulin resistance is associated with hepatic overproduction of atherogenic lipoproteins and triglycerides, along with progressive pancreatic beta-cell dysfunction and the development of type 2 diabetes [].
evidence level1
citationKang Chae-Yeon (2026)
sourceCoptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study
topicBerberine Glycemic Control Meta-Analysis
claimStatin-associated muscle symptoms and metformin-related gastrointestinal intolerance have also been reported to affect treatment persistence in some patients [,,].
evidence level1
citationKang Chae-Yeon (2026)
sourceCoptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study
topicBerberine Glycemic Control Meta-Analysis
claim1 2 3 4 5 6 7 Obesity, diabetes, and dyslipidemia form an interconnected cluster of metabolic disorders that together impose a substantial burden on global healthcare systems [].
evidence level1
citationKang Chae-Yeon (2026)
sourceCoptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study
topicBerberine Glycemic Control Meta-Analysis
claimMethods: We conducted a narrative review to integrate current evidence on the classification, bioavailability, molecular targets, microbiota interactions, and clinical relevance of dietary BCs.
evidence level4
citationDos Santos EA (2026)
sourceDietary Bioactive Compounds: Cellular Sensory Pathways, Microbial Partners, and Clinical Realities.
topicBerberine Glycemic Control Meta-Analysis
claimAcross obesity, type 2 diabetes, cardiovascular disease, inflammatory bowel disease, and neurodegenerative conditions, BCs appear associated with improved inflammatory, metabolic, and redox regulation.
evidence level4
citationDos Santos EA (2026)
sourceDietary Bioactive Compounds: Cellular Sensory Pathways, Microbial Partners, and Clinical Realities.
topicBerberine Glycemic Control Meta-Analysis
claimHowever, greater standardization in study design and longer-term human trials are needed to support robust evidence-based recommendations.
evidence level4
citationDos Santos EA (2026)
sourceDietary Bioactive Compounds: Cellular Sensory Pathways, Microbial Partners, and Clinical Realities.
topicBerberine Glycemic Control Meta-Analysis
claimBackground/Objectives: Dietary bioactive compounds (BCs) modulate multiple cellular pathways involved in inflammation, oxidative stress, energy metabolism, and tissue homeostasis.
evidence level4
citationDos Santos EA (2026)
sourceDietary Bioactive Compounds: Cellular Sensory Pathways, Microbial Partners, and Clinical Realities.